These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4801443)

  • 21. Effect of oral contraceptive on liver function tests of women with schistosomiasis in the Philippines.
    Sy FS; Osteria TS; Opiniano V; Gler S
    Contraception; 1986 Sep; 34(3):283-94. PubMed ID: 3098499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Masculinization of the female fetus associated with norethindrone-mestranol therapy during pregnancy.
    Voorhess ML
    J Pediatr; 1967 Jul; 71(1):128-31. PubMed ID: 5293850
    [No Abstract]   [Full Text] [Related]  

  • 23. Side effects of cyclic therapy with norethindrone and mestranol.
    Chernick BA
    Fertil Steril; 1965; 16(4):445-54. PubMed ID: 5874266
    [No Abstract]   [Full Text] [Related]  

  • 24. Amenorrhea following use of oral contraceptives.
    Rifkin I; Nachtigall LE; Beckman EM
    Am J Obstet Gynecol; 1972 Jun; 113(3):420-32. PubMed ID: 4678381
    [No Abstract]   [Full Text] [Related]  

  • 25. The pelvic congestive effects of norethindorne plus mestranol.
    Boatwright B; Kaufman RH
    Fertil Steril; 1968; 19(2):161-71. PubMed ID: 5640704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term study of oral contraception with norethindrone 2 mg. and mestranol 0.1 mg.
    Hutcherson WP; Schwartz HA; Weathers W
    Fertil Steril; 1966; 17(1):59-67. PubMed ID: 5901012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of norethindrone combined with mestranol (S-3800 C) as an oral contraceptive].
    Seiga K
    Iryo; 1968 Apr; 22(4):444-52. PubMed ID: 5686370
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral contraceptives and thromboembolic disease. I. Prospective and retrospective studies.
    Drill VA
    JAMA; 1972 Jan; 219(5):583-92. PubMed ID: 5066803
    [No Abstract]   [Full Text] [Related]  

  • 29. Ovarian morphology following cyclic norethindrone-mestranol therapy.
    Zussman WV; Forbes DA; Carpenter RJ
    Am J Obstet Gynecol; 1967 Sep; 99(1):99-105. PubMed ID: 6034978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modifications in the menstrual pattern during use of hormonal contraceptives].
    de Sampaio LF; Novo NF; de Paiva ER
    Matern Infanc (Sao Paulo); 1974; 33(3):367-70. PubMed ID: 4466962
    [No Abstract]   [Full Text] [Related]  

  • 31. Two oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial.
    Flodgaard D; Helles A; Jacobsen M
    Contraception; 1975 Jul; 12(1):77-88. PubMed ID: 1095298
    [No Abstract]   [Full Text] [Related]  

  • 32. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
    Coutinho EM; Silva AR; Carreira C; Barbosa I
    Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adverse effects of oral contraceptives].
    Adam H; Schirmer B
    Z Arztl Fortbild (Jena); 1973 Nov; 67(21):1078-81. PubMed ID: 4130135
    [No Abstract]   [Full Text] [Related]  

  • 34. Side effects of oral contraceptives.
    Pulkkinen MO
    Acta Obstet Gynecol Scand; 1966; 45(S9):42. PubMed ID: 5958396
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].
    Miyawaki Y; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration.
    Mills TM; Lin TJ; Braselton WE; Ellegood JO; Mahesh VB
    Am J Obstet Gynecol; 1976 Dec; 126(8):987-92. PubMed ID: 998688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.
    Elstein M; Briston PG; Jenkins M; Kirk D; Miller H
    Br Med J; 1974 Jan; 1(5896):11-3. PubMed ID: 4808812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraceptives and jaundice.
    Card IR; Sneddon IB; Talbot CH
    Br Med J; 1966 Mar; 1(5489):739-40. PubMed ID: 5909490
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group.
    Cromie MA; Maile MH; Wajszczuk CP
    Contraception; 2000 Jan; 61(1):51-9. PubMed ID: 10745070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.